Coherus Announces Proposed Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Coherus BioSciences (CHRS) Prices Larger 4.14M Common Offering at $29/Share
April 1, 2015 5:55 AM EDTCoherus BioSciences (NASDAQ: CHRS) announced the pricing of its underwritten public offering of 4,137,931 shares of its common stock at a price to the public of $29.00 per share. All of the shares of the common stock to be sold in the offering will be... More
